{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T05:27:38Z","timestamp":1782019658101,"version":"3.54.5"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,10,2]],"date-time":"2021-10-02T00:00:00Z","timestamp":1633132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,2]],"date-time":"2021-10-02T00:00:00Z","timestamp":1633132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Bonn"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl. Stroke Res."],"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We hypothesized that the enzyme arginase-1 is released into the cerebrospinal fluid (CSF) during red blood cell lysis and contributes to dysregulated metabolism of the nitric oxide (NO) precursor L-arginine during aneurysmal subarachnoid hemorrhage (SAH). This prospective case\u2013control study included 43 patients with aneurysmal SAH and ventricular drainage for clinical reasons. Longitudinal CSF samples (99) were obtained in the course of SAH. Patients were dichotomized regarding the occurrence of cerebral vasospasm syndrome (CVS) (<jats:italic>N<\/jats:italic>\u2009=\u200919). Arginase-1 and the amino acids L-arginine and L-ornithine were quantified in CSF. Outcome assessments included delayed cerebral ischemia (DCI) and functional status after 3\u00a0months using the modified Rankin Scale (mRS). Arginase-1 was released into the CSF of SAH patients whereas this enzyme was undetectable in controls. Compared to patients without CVS, arginase-1 levels were higher in CVS patients until day 14 after clinical event. The well-known surrogate parameter for arginase acitivity, the L-arginine to L-ornithine ratio (Arg\/Orn), correlated with CSF arginase-1 levels. Arg\/Orn was reduced in patients with CVS from disease onset (days 1\u20133, <jats:italic>p<\/jats:italic>\u2009=\u20090.0009) until day 14. Logistic regression analysis of early Arg\/Orn was predictive for CVS (<jats:italic>p<\/jats:italic>\u2009=\u20090.008) and DCI (<jats:italic>p<\/jats:italic>\u2009=\u20090.035), independent of age, Hunt and Hess grade, and intraventricular blood. Arg\/Orn\u2009&lt;\u20092.71 at disease onset predicted CVS with a sensitivity of 86.7% and specificity of 72.2%. Arg\/Orn\u2009\u2265\u20092.71 predicted excellent functional outcome. We propose a novel mechanism contributing to NO deprivation during SAH: arginase-1 is released from erythrocytes into the CSF, leading to L-arginine consumption and reduced NO bioavailability. Furthermore, Arg\/Orn is a robust predictor for occurrence of CVS, DCI, and functional outcome 3\u00a0months after aneurysmal SAH. Our data provide a novel prognostic biomarker and may contribute to the development of novel therapeutic strategies in SAH. Clinical Trial Registration-URL: <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.drks.de\">http:\/\/www.drks.de<\/jats:ext-link>. Unique identifier: DRKS00015293, date of registration: 13.09.2018.<\/jats:p>","DOI":"10.1007\/s12975-021-00944-y","type":"journal-article","created":{"date-parts":[[2021,10,2]],"date-time":"2021-10-02T03:37:34Z","timestamp":1633145854000},"page":"382-390","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Arginase-1 Released into CSF After Aneurysmal Subarachnoid Hemorrhage Decreases Arginine\/Ornithine Ratio: a Novel Prognostic Biomarker"],"prefix":"10.1007","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1964-0078","authenticated-orcid":false,"given":"Julian","family":"Zimmermann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Weller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Grub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sied","family":"Kebir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut","family":"Vatter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Schuss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erdem","family":"G\u00fcresir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,2]]},"reference":[{"key":"944_CR1","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1161\/01.STR.19.10.1300","volume":"19","author":"J Biller","year":"1988","unstructured":"Biller J, Godersky JC, Adams HP. Management of aneurysmal subarachnoid hemorrhage. Stroke. 1988;19:1300\u20135.","journal-title":"Stroke"},{"key":"944_CR2","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/S0140-6736(05)67214-5","volume":"366","author":"AJ Molyneux","year":"2005","unstructured":"Molyneux AJ, Kerr RSC, Yu L-M, Clarke M, Sneade M, Yarnold JA, et al. International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion. Lancet Lond Engl. 2005;366:809\u201317.","journal-title":"Lancet Lond Engl"},{"key":"944_CR3","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s00234-009-0575-y","volume":"51","author":"JW Dankbaar","year":"2009","unstructured":"Dankbaar JW, Rijsdijk M, van der Schaaf IC, Velthuis BK, Wermer MJH, Rinkel GJE. Relationship between vasospasm, cerebral perfusion, and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Neuroradiology. 2009;51:813\u20139.","journal-title":"Neuroradiology"},{"key":"944_CR4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.pharmthera.2004.10.002","volume":"105","author":"RM Pluta","year":"2005","unstructured":"Pluta RM. Delayed cerebral vasospasm and nitric oxide: review, new hypothesis, and proposed treatment. Pharmacol Ther. 2005;105:23\u201356.","journal-title":"Pharmacol Ther"},{"key":"944_CR5","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1097\/00004647-200204000-00011","volume":"22","author":"JF Clark","year":"2002","unstructured":"Clark JF, Reilly M, Sharp FR. Oxidation of bilirubin produces compounds that cause prolonged vasospasm of rat cerebral vessels: a contributor to subarachnoid hemorrhage-induced vasospasm. J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab. 2002;22:472\u20138.","journal-title":"J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab"},{"key":"944_CR6","doi-asserted-by":"publisher","first-page":"18709","DOI":"10.1074\/jbc.273.30.18709","volume":"273","author":"X Liu","year":"1998","unstructured":"Liu X, Miller MJ, Joshi MS, Sadowska-Krowicka H, Clark DA, Lancaster JR. Diffusion-limited reaction of free nitric oxide with erythrocytes. J Biol Chem. 1998;273:18709\u201313.","journal-title":"J Biol Chem"},{"key":"944_CR7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/0304-3940(93)90343-J","volume":"149","author":"U Dirnagl","year":"1993","unstructured":"Dirnagl U, Lindauer U, Villringer A. Role of nitric oxide in the coupling of cerebral blood flow to neuronal activation in rats. Neurosci Lett. 1993;149:43\u20136.","journal-title":"Neurosci Lett"},{"key":"944_CR8","doi-asserted-by":"publisher","first-page":"746","DOI":"10.3171\/jns.1997.87.5.0746","volume":"87","author":"RM Pluta","year":"1997","unstructured":"Pluta RM, Oldfield EH, Boock RJ. Reversal and prevention of cerebral vasospasm by intracarotid infusions of nitric oxide donors in a primate model of subarachnoid hemorrhage. J Neurosurg. 1997;87:746\u201351.","journal-title":"J Neurosurg"},{"key":"944_CR9","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1089\/ars.2007.1959","volume":"10","author":"K Chen","year":"2008","unstructured":"Chen K, Pittman RN, Popel AS. Nitric oxide in the vasculature: where does it come from and where does it go? A quantitative perspective Antioxid Redox Signal. 2008;10:1185\u201398.","journal-title":"A quantitative perspective Antioxid Redox Signal"},{"key":"944_CR10","doi-asserted-by":"publisher","first-page":"E75","DOI":"10.1152\/ajpendo.2001.280.1.E75","volume":"280","author":"H Li","year":"2001","unstructured":"Li H, Meininger CJ, Hawker JR, Haynes TE, Kepka-Lenhart D, Mistry SK, et al. Regulatory role of arginase I and II in nitric oxide, polyamine, and proline syntheses in endothelial cells. Am J Physiol Endocrinol Metab. 2001;280:E75-82.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"944_CR11","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/S1096-7192(02)00034-3","volume":"76","author":"PS Kim","year":"2002","unstructured":"Kim PS, Iyer RK, Lu KV, Yu H, Karimi A, Kern RM, et al. Expression of the liver form of arginase in erythrocytes. Mol Genet Metab. 2002;76:100\u201310.","journal-title":"Mol Genet Metab"},{"key":"944_CR12","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0378-1119(97)00099-1","volume":"193","author":"SM Morris","year":"1997","unstructured":"Morris SM, Bhamidipati D, Kepka-Lenhart D. Human type II arginase: sequence analysis and tissue-specific expression. Gene. 1997;193:157\u201361.","journal-title":"Gene"},{"key":"944_CR13","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1001\/jama.294.1.81","volume":"294","author":"CR Morris","year":"2005","unstructured":"Morris CR, Kato GJ, Poljakovic M, Wang X, Blackwelder WC, Sachdev V, et al. Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. JAMA. 2005;294:81\u201390.","journal-title":"JAMA"},{"key":"944_CR14","first-page":"117","volume":"4","author":"EE Lin","year":"2005","unstructured":"Lin EE, Rodgers GP, Gladwin MT. Hemolytic anemia-associated pulmonary hypertension in sickle cell disease. Curr Hematol Rep. 2005;4:117\u201325.","journal-title":"Curr Hematol Rep"},{"key":"944_CR15","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1196\/annals.1345.058","volume":"1054","author":"CR Morris","year":"2005","unstructured":"Morris CR, Kuypers FA, Kato GJ, Lavrisha L, Larkin S, Singer T, et al. Hemolysis-associated pulmonary hypertension in thalassemia. Ann N Y Acad Sci. 2005;1054:481\u20135.","journal-title":"Ann N Y Acad Sci"},{"key":"944_CR16","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1111\/j.1365-2141.2010.08096.x","volume":"149","author":"A Hill","year":"2010","unstructured":"Hill A, Rother RP, Wang X, Morris SM, Quinn-Senger K, Kelly R, et al. Effect of eculizumab on haemolysis-associated nitric oxide depletion, dyspnoea, and measures of pulmonary hypertension in patients with paroxysmal nocturnal haemoglobinuria. Br J Haematol. 2010;149:414\u201325.","journal-title":"Br J Haematol"},{"key":"944_CR17","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.1007\/s00415-018-9091-5","volume":"265","author":"P Schuss","year":"2018","unstructured":"Schuss P, Hadjiathanasiou A, Brandecker S, G\u00fcresir \u00c1, Vatter H, G\u00fcresir E. Elevated C-reactive protein and white blood cell count at admission predict functional outcome after non-aneurysmal subarachnoid hemorrhage. J Neurol. 2018;265:2944\u20138.","journal-title":"J Neurol"},{"key":"944_CR18","doi-asserted-by":"crossref","unstructured":"Frontera Jennifer A., Fernandez Andres, Schmidt J. Michael, Claassen Jan, Wartenberg Katja E., Badjatia Neeraj, et al. Defining vasospasm after subarachnoid hemorrhage. Stroke. American Heart Association; 2009;40:1963\u20138.","DOI":"10.1161\/STROKEAHA.108.544700"},{"key":"944_CR19","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3171\/jns.1990.72.5.0775","volume":"72","author":"JW Peterson","year":"1990","unstructured":"Peterson JW, Roussos L, Kwun BD, Hackett JD, Owen CJ, Zervas NT. Evidence of the role of hemolysis in experimental cerebral vasospasm. J Neurosurg. 1990;72:775\u201381.","journal-title":"J Neurosurg"},{"key":"944_CR20","doi-asserted-by":"crossref","unstructured":"Harada T, Suzuki Y, Satoh S, Ikegaki I, Asano T, Shibuya M, et al. Blood component induction of cerebral vasospasm. Neurosurgery. 1990;27:252\u20135; discussion 255\u2013256.","DOI":"10.1227\/00006123-199008000-00014"},{"key":"944_CR21","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.neulet.2012.06.076","volume":"524","author":"CS Jung","year":"2012","unstructured":"Jung CS, Lange B, Zimmermann M, Seifert V. The CSF concentration of ADMA, but not of ET-1, is correlated with the occurrence and severity of cerebral vasospasm after subarachnoid hemorrhage. Neurosci Lett. 2012;524:20\u20134.","journal-title":"Neurosci Lett"},{"key":"944_CR22","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1016\/S0140-6736(16)00647-4","volume":"387","author":"MT Gladwin","year":"2016","unstructured":"Gladwin MT. Cardiovascular complications and risk of death in sickle-cell disease. Lancet Lond Engl. 2016;387:2565\u201374.","journal-title":"Lancet Lond Engl"},{"key":"944_CR23","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1182\/blood-2015-08-618561","volume":"127","author":"VR Gordeuk","year":"2016","unstructured":"Gordeuk VR, Castro OL, Machado RF. Pathophysiology and treatment of pulmonary hypertension in sickle cell disease. Blood. 2016;127:820\u20138.","journal-title":"Blood"},{"key":"944_CR24","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhl\u00e9n","year":"2015","unstructured":"Uhl\u00e9n M, Fagerberg L, Hallstr\u00f6m BM, Lindskog C, Oksvold P, Mardinoglu A, et al. Proteomics Tissue-based map of the human proteome. Science. 2015;347:1260419.","journal-title":"Science."},{"key":"944_CR25","doi-asserted-by":"publisher","first-page":"C393","DOI":"10.1152\/ajpcell.1982.242.5.C393","volume":"242","author":"JA Williams","year":"1982","unstructured":"Williams JA, Phang JM. Production of ornithine by intact human erythrocytes. Am J Physiol. 1982;242:C393-397.","journal-title":"Am J Physiol"},{"key":"944_CR26","first-page":"1138","volume":"37","author":"EB Spector","year":"1985","unstructured":"Spector EB, Rice SC, Kern RM, Hendrickson R, Cederbaum SD. Comparison of arginase activity in red blood cells of lower mammals, primates, and man: evolution to high activity in primates. Am J Hum Genet. 1985;37:1138\u201345.","journal-title":"Am J Hum Genet"},{"key":"944_CR27","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1161\/STROKEAHA.111.000605","volume":"44","author":"JM Staals\u00f8","year":"2013","unstructured":"Staals\u00f8 JM, Bergstr\u00f6m A, Edsen T, Weikop P, Romner B, Olsen NV. Low plasma arginine:asymmetric dimethyl arginine ratios predict mortality after intracranial aneurysm rupture. Stroke J Cereb Circ. 2013;44:1273\u201381.","journal-title":"Stroke J Cereb Circ"},{"key":"944_CR28","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jneumeth.2007.04.005","volume":"164","author":"J Martens-Lobenhoffer","year":"2007","unstructured":"Martens-Lobenhoffer J, Sulyok E, Czeiter E, B\u00fcki A, Kohl J, Firsching R, et al. Determination of cerebrospinal fluid concentrations of arginine and dimethylarginines in patients with subarachnoid haemorrhage. J Neurosci Methods. 2007;164:155\u201360.","journal-title":"J Neurosci Methods"},{"key":"944_CR29","first-page":"2752S","volume":"134","author":"EI Closs","year":"2004","unstructured":"Closs EI, Simon A, V\u00e9kony N, Rotmann A. Plasma membrane transporters for arginine. J Nutr Oxford Academic. 2004;134:2752S-2759S.","journal-title":"J Nutr Oxford Academic"},{"key":"944_CR30","doi-asserted-by":"crossref","unstructured":"Frontera JA, Claassen J, Schmidt JM, Wartenberg KE, Temes R, Connolly ES, et al. Prediction of symptomatic vasospasm after subarachnoid hemorrhage: the modified fisher scale. Neurosurgery. 2006;59:21\u20137; discussion 21\u201327.","DOI":"10.1227\/01.NEU.0000218821.34014.1B"},{"key":"944_CR31","doi-asserted-by":"crossref","unstructured":"Chou SH-Y, Macdonald RL, Keller E, Suarez JI, Amin-Hanjani S, Brown RD, et al. Biospecimens and molecular and cellular biomarkers in aneurysmal subarachnoid hemorrhage studies: common data elements and standard reporting recommendations. Neurocrit Care. 2019;30:46\u201359.","DOI":"10.1007\/s12028-019-00725-4"},{"key":"944_CR32","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.3171\/2014.7.JNS131704","volume":"121","author":"K-C Wang","year":"2014","unstructured":"Wang K-C, Tang S-C, Lee J-E, Lai D-M, Huang S-J, Hsieh S-T, et al. Prognostic value of intrathecal heme oxygenase-1 concentration in patients with Fisher Grade III aneurysmal subarachnoid hemorrhage. J Neurosurg. 2014;121:1388\u201393.","journal-title":"J Neurosurg"},{"key":"944_CR33","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1161\/01.STR.22.8.971","volume":"22","author":"RL Macdonald","year":"1991","unstructured":"Macdonald RL, Weir BK. A review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke. 1991;22:971\u201382.","journal-title":"Stroke"},{"key":"944_CR34","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/S1474-4422(11)70108-9","volume":"10","author":"RL Macdonald","year":"2011","unstructured":"Macdonald RL, Higashida RT, Keller E, Mayer SA, Molyneux A, Raabe A, et al. Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2). Lancet Neurol. 2011;10:618\u201325.","journal-title":"Lancet Neurol"},{"key":"944_CR35","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.drudis.2013.05.017","volume":"18","author":"JE Piletz","year":"2013","unstructured":"Piletz JE, Aricioglu F, Cheng J-T, Fairbanks CA, Gilad VH, Haenisch B, et al. Agmatine: clinical applications after 100 years in translation. Drug Discov Today. 2013;18:880\u201393.","journal-title":"Drug Discov Today"},{"key":"944_CR36","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s00726-008-0210-y","volume":"37","author":"G Wu","year":"2009","unstructured":"Wu G, Bazer FW, Davis TA, Kim SW, Li P, Marc Rhoads J, et al. Arginine metabolism and nutrition in growth, health and disease. Amino Acids. 2009;37:153\u201368.","journal-title":"Amino Acids"},{"key":"944_CR37","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1182\/blood.V104.11.237.237","volume":"104","author":"CR Morris","year":"2004","unstructured":"Morris CR, Kato G, Poljakovic M, Blackwelder WC, Hazen S, Vichinsky EP, et al. The arginine-to-ornithine ratio: biomarker of arginase activity and predictor of mortality in sickle cell disease. Blood. 2004;104:237\u2013237.","journal-title":"Blood"},{"key":"944_CR38","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/BF01809241","volume":"78","author":"H von Holst","year":"1985","unstructured":"von Holst H, Hagenfeldt L. Increased levels of amino acids in human lumbar and central cerebrospinal fluid after subarachnoid haemorrhage. Acta Neurochir (Wien). 1985;78:46\u201356.","journal-title":"Acta Neurochir (Wien)"},{"key":"944_CR39","doi-asserted-by":"crossref","unstructured":"Sok\u00f3\u0142 B, Urbaniak B, W\u0105sik N, Plewa S, Klupczy\u0144ska A, Jankowski R, et al. Amino acids in cerebrospinal fluid of patients with aneurysmal subarachnoid haemorrhage: an observational study. Front Neurol [Internet]. 2017; 8:438.","DOI":"10.3389\/fneur.2017.00438"},{"key":"944_CR40","doi-asserted-by":"crossref","unstructured":"Li Y-C, Wang R, Xu M-M, Jing X-R, A J-Y, Sun R-B, et al. Aneurysmal subarachnoid hemorrhage onset alters pyruvate metabolism in poor-grade patients and clinical outcome depends on more: a cerebrospinal fluid metabolomic study. ACS Chem Neurosci American Chemical Society; 2019;10:1660\u20137.","DOI":"10.1021\/acschemneuro.8b00581"},{"key":"944_CR41","doi-asserted-by":"crossref","unstructured":"Mader MM, B\u00f6ger R, Appel D, Schwedhelm E, Haddad M, Mohme M, et al. Intrathecal and systemic alterations of L-arginine metabolism in patients after intracerebral hemorrhage. J Cereb Blood Flow Metab. SAGE Publications Ltd STM; 2021;0271678X20983216.","DOI":"10.1177\/0271678X20983216"},{"key":"944_CR42","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1002\/med.21419","volume":"37","author":"M Pudlo","year":"2017","unstructured":"Pudlo M, Demougeot C, Girard-Thernier C. Arginase inhibitors: a rational approach over one century. Med Res Rev. 2017;37:475\u2013513.","journal-title":"Med Res Rev"},{"key":"944_CR43","doi-asserted-by":"crossref","unstructured":"Kajita Y, Suzuki Y, Oyama H, Tanazawa T, Takayasu M, Shibuya M, et al. Combined effect of L-arginine and superoxide dismutase on the spastic basilar artery after subarachnoid hemorrhage in dogs. J Neurosurg. Journal of Neurosurgery Publishing Group; 1994;80:476\u201383.","DOI":"10.3171\/jns.1994.80.3.0476"},{"key":"944_CR44","doi-asserted-by":"publisher","first-page":"e443","DOI":"10.1016\/j.wneu.2019.08.119","volume":"132","author":"E Akar","year":"2019","unstructured":"Akar E, Emon ST, Uslu S, Orakdogen M, Somay H. Effect of L-arginine therapy on vasospasm: experimental study in rats. World Neurosurg. 2019;132:e443\u20136.","journal-title":"World Neurosurg"},{"key":"944_CR45","doi-asserted-by":"crossref","unstructured":"Pluta RM, Afshar JKB, Thompson BG, Boock RJ, Harvey-White J, Oldfield EH. Increased cerebral blood flow but no reversal or prevention of vasospasm in response to l-arginine infusion after subarachnoid hemorrhage. J Neurosurg. Journal of Neurosurgery Publishing Group; 2000;92:121\u20136.","DOI":"10.3171\/jns.2000.92.1.0121"}],"container-title":["Translational Stroke Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-021-00944-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12975-021-00944-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-021-00944-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T05:11:06Z","timestamp":1651036266000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12975-021-00944-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,2]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["944"],"URL":"https:\/\/doi.org\/10.1007\/s12975-021-00944-y","relation":{},"ISSN":["1868-4483","1868-601X"],"issn-type":[{"value":"1868-4483","type":"print"},{"value":"1868-601X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,2]]},"assertion":[{"value":"21 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was registered in the German Clinical Trials Register (DRKS-ID: DRKS00015293). All procedures were performed in line with the principles of the Declaration of Helsinki. Approval was granted by the local ethics committee of the University hospital of Bonn.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study, their legal guardians, or their relatives.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}